Sunshine Biopharma Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
Sunshine Biopharma Inc. (SBFM) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $18.86 million as of 2022-10-20, per its 10-K filed 2023-04-04.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2023-04-04
- 2022-10-20: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $18.86M.
- 2019-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $676.75K.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $676.75K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2022-10-20 | $18.86M 10-K · filed 2023-04-04 |
| 2019-12-31 | $676.75K 10-K · filed 2021-03-30 |
| 2018-12-31 | $676.75K 10-K · filed 2020-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |